ACTG 185

ACTG 185

AIDS Clinical Trial Group Study 185, Use of HIVIG for the Prevention of Maternal/Fetal HIV Transmission. A study that concluded that HIV hyperimmune globulin is ineffective in reducing the risk of perinatal HIV transmission in women with advanced HIV-related disease.
References in periodicals archive ?
professor, chief, Division of Pediatric Immunology/Allergy, Department of Pediatrics, UCLA Medical Center, Stiehm is co-chair of the NIH Protocol ACTG 185, evaluating the use of HIV Immune Globulin in the prevention of maternal/fetal HIV transmission, scheduled to begin in September.